50 Participants Needed

Nutritional Optimization for Heart Failure

(ENOL Trial)

AL
MY
Overseen ByMelana Yuzefpolskaya, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Columbia University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to assess whether a peri-operative intervention with nutritional immune modulating intervention (Ensure Surgery Immunonutrition shake) has beneficial effects on the complex interplay between gut microbiome, systemic inflammation and malnutrition that is commonly present in advanced heart failure and the adverse events associated with left ventricular assist device (LVAD) placement in hospitalized advanced heart failure patients awaiting LVAD implantation. The main questions it aims to answer are: * Will pre-surgical supplementation with Ensure Surgery affect gut microbial composition and levels of inflammation among heart failure patients undergoing LVAD implantation? * Will pre-surgical supplementation with Ensure Surgery affect post-surgical morbidity (e.g., infections, intensive care unit length of stay (LOS)) and mortality? Participants will be evaluated for malnutrition and will be given Ensure Surgery Immunonutrition shake to drink in the days preceding their LVAD surgery. Blood and stool samples will be collected at prespecified timepoints before and after surgery. Researchers will compare malnourished participants drinking Ensure Surgery 3/day with well-nourished participants randomized to drink either 1/day or 3/day to see if any of the above supplementation strategies change the gut microbial composition, levels of inflammation, and post-surgical morbidity and mortality.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Ensure Surgery Immunonutrition shake and related drinks for heart failure?

Research shows that nutritional drinks, like those used in surgeries, can help reduce complications and improve recovery by providing essential nutrients and reducing stress on the body. While not specific to heart failure, these benefits might also support heart health.12345

Is the nutritional treatment generally safe for humans?

The studies suggest that nutritional supplements, including those similar to Ensure products, are generally safe for use in humans, as they have been used in various medical conditions like surgery recovery and heart failure without major safety concerns.13467

How does the Nutritional Optimization for Heart Failure treatment differ from other treatments for heart failure?

The Nutritional Optimization for Heart Failure treatment is unique because it focuses on optimizing nutrition, potentially using specialized nutritional supplements, to support heart health, unlike traditional heart failure treatments that primarily involve medications or surgical interventions. This approach may include components like arginine-enriched supplements, which have shown benefits in surgical recovery, suggesting a novel way to manage heart failure by enhancing the body's nutritional status.14589

Research Team

MY

Melana Yuzefpolskaya, MD

Principal Investigator

Columbia University

Eligibility Criteria

This trial is for adults over 18 with advanced heart failure who are hospitalized and awaiting LVAD implantation. They must be able to eat by mouth and not have congenital heart disease, infiltrative cardiomyopathy, or require intubation. Surgery should not be expected within the next 5 days.

Inclusion Criteria

I am currently receiving LVAD therapy.
I am currently in the hospital.
I am older than 18 years.

Exclusion Criteria

I was born with a heart condition.
My surgery is scheduled within the next 5 days.
I am currently on a breathing machine.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-operative Nutritional Intervention

Participants receive Ensure Surgery Immunonutrition shake to optimize nutritional status before LVAD implantation

Approximately 5 days
Daily monitoring

Surgery and Immediate Post-operative

Participants undergo LVAD implantation and are monitored for immediate post-operative outcomes

Approximately 25 days
In-hospital stay

Follow-up

Participants are monitored for safety and effectiveness after discharge, including changes in biomarkers and microbiome

Approximately 30 days post-discharge
Regular follow-up visits

Treatment Details

Interventions

  • Ensure Surgery Immunonutrition shake
Trial Overview Researchers are testing if drinking Ensure Surgery Immunonutrition shake before surgery can improve gut health, reduce inflammation, and decrease complications after getting an LVAD. Malnourished patients will drink it three times a day while well-nourished ones will be randomly chosen to drink once or thrice daily.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: Group 2 (at risk/malnourished)Experimental Treatment1 Intervention
Patients assessed as at risk for malnourishment or malnourished based on AND-ASPEN criteria automatically assigned to receive 3 Ensure Surgery Immunonutrition shake per day during the days from consent to LVAD implantation.
Group II: Group 1 (Not malnourished) - 3 products per dayExperimental Treatment1 Intervention
Patients assessed as well-nourished based on AND-ASPEN criteria and randomized to receive 3 Ensure Surgery Immunonutrition shake per day during the days from consent to LVAD implantation.
Group III: Group 1 (Not malnourished) - 1 product per dayExperimental Treatment1 Intervention
Patients assessed as well-nourished based on AND-ASPEN criteria and randomized to receive 1 Ensure Surgery Immunonutrition shake per day during the days from consent to LVAD implantation.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

Abbott Nutrition

Industry Sponsor

Trials
173
Recruited
33,700+
Robert B. Ford profile image

Robert B. Ford

Abbott Nutrition

Chief Executive Officer since 2020

Bachelor's degree from Boston College, MBA from UC Berkeley, Haas School of Business

Melissa Brotz profile image

Melissa Brotz

Abbott Nutrition

Chief Marketing Officer

Bachelor's degree in Journalism from Northwestern University

Findings from Research

In a study of 45 postoperative patients with esophageal carcinoma, the enteral nutrition formulas Ensure and Nutrison led to faster recovery of gastrointestinal function compared to Peptison, with recovery times of approximately 52.4 and 50.8 hours respectively, versus 60.3 hours for Peptison.
All three nutrition formulas showed similar safety profiles and effectiveness in improving nutritional indices, but Ensure was significantly more cost-effective, costing about 443.3 RMB compared to 639.5 RMB for Nutrison and 990.5 RMB for Peptison.
[Study of different enteral nutrition formulation treatment after esophagectomy].Liu, SY., Chen, XF., Wang, F., et al.[2012]
Laparoscopic procedures enable earlier oral intake after colorectal surgery, which is a key component of enhanced recovery after surgery (ERAS) programs.
Implementing ERAS protocols, such as consuming a carbohydrate-rich beverage before surgery and allowing oral liquid intake on the day of surgery, can lead to reduced postoperative complications and shorter hospital stays.
[Current practices of perioperative nutritional therapy in colorectal surgery].Ohge, H., Okajima, M., Hinoi, T., et al.[2011]
In a study of 60 patients undergoing open colorectal surgery, preoperative carbohydrate (CHO) drinks significantly reduced postoperative neutrophil-to-lymphocyte ratio (NLR) values, indicating a lower inflammatory response compared to those who fasted before surgery.
The CHO group experienced no major postoperative complications, while the fasting group had a higher incidence of severe complications, suggesting that preoperative carbohydrate loading may enhance recovery and reduce surgical stress.
Effects of Preoperative Oral Carbohydrate Loading on Neutrophil/Lymphocyte Ratio and Postoperative Complications following Colorectal Cancer Surgery: A Randomized Controlled Study.Rizvanoviฤ‡, N., Nesek Adam, V., Kalajdลพija, M., et al.[2023]

References

[Study of different enteral nutrition formulation treatment after esophagectomy]. [2012]
[Current practices of perioperative nutritional therapy in colorectal surgery]. [2011]
Effects of Preoperative Oral Carbohydrate Loading on Neutrophil/Lymphocyte Ratio and Postoperative Complications following Colorectal Cancer Surgery: A Randomized Controlled Study. [2023]
Preoperative Immunonutrition and Elective Colorectal Resection Outcomes. [2019]
Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers: a randomised double-blind, crossover study. [2009]
Early enteral nutrition in patients with hemodynamic failure following cardiac surgery. [2022]
Oral nutritional supplement use in relation to length of stay in heart failure patients at a regional medical center. [2022]
Cellular mechanisms underlying the protective effects of preoperative feeding: a randomized study investigating muscle and liver glycogen content, mitochondrial function, gene and protein expression. [2021]
[INFLUENCE TIMING OF THE START OF ENTERAL NUTRITION ON THE IMMEDIATE RESULTS OF SURGICAL TREATMENT OF COLON CANCER]. [2016]